文献速递口腔修复与种植牙周病

比较结缔组织移植与胶原基质增加单颗种植体颊侧软组织厚度的多中心随机对照试验:1年结果

A multi-centre randomized controlled trial comparing connective tissue graft with collagen matrix to increase soft tissue thickness at the buccal aspect of single implants: 1-year results.
PubMed 文献 · J Clin Periodontol · 2022-07-20

这项多中心随机对照试验纳入上前牙区单牙缺失伴水平黏膜缺损患者,比较结缔组织移植(CTG)与胶原基质(CMX)增加颊侧软组织厚度1年时的效果。结果显示CTG组颊侧软组织轮廓增加0.98 mm(98.3%CI 0.75-1.20),CMX组为0.57 mm(98.3%CI 0.34-0.79),组间差异0.41 mm(98.3%CI 0.12-0.69)有利于CTG且显著(p<.001);CMX组收缩更多且边缘骨吸收更多。作者结论认为CTG仍是增加种植位点软组织厚度的金标准,临床需权衡CMX获益与移植物吸收。

要点

  • CTG组颊侧软组织轮廓1年增加0.98 mm,CMX组0.57 mm,组间差异0.41 mm有利于CTG且显著。
  • 以0.75 mm增加为成功阈值,CTG组89.7%患者成功,CMX组仅10%成功(OR=77.90)。
  • CMX组术后至1年收缩较CTG组多0.89 mm,且边缘骨吸收较CTG组多0.39 mm。

核心结论

  • 作者结论认为结缔组织移植仍是增加种植位点软组织厚度的金标准。
  • 作者指出临床医生需权衡胶原基质的获益与其相当程度的移植物吸收。

研究设计与样本

  • 多中心随机对照试验,纳入上前牙区单牙缺失伴水平黏膜缺损患者,所有位点颊腭向骨尺寸至少6 mm。
  • 所有位点接受单颗种植体并采用全数字化流程即刻修复,随机分配至对照组(结缔组织移植)或试验组(胶原基质)以增加颊侧软组织厚度。
  • 每组纳入30例患者(对照组女性50%,平均年龄50.1岁;试验组女性53%,平均年龄48.2岁)。
  • 主要结局为基于重叠数字化表面模型比较术前与1年时颊侧软组织轮廓的增加量,感兴趣区为从软组织边缘下方0.5 mm至更根方4 mm的颊侧区域。
  • 研究注册于ClinicalTrials.gov(NCT04210596)。

主要发现

  • 1年时颊侧软组织轮廓增加:结缔组织移植组0.98 mm(98.3%CI 0.75-1.20),胶原基质组0.57 mm(98.3%CI 0.34-0.79)。
  • 组间平均差异0.41 mm(98.3%CI 0.12-0.69)有利于结缔组织移植且显著(p<.001)。
  • 以任意选定的0.75 mm颊侧软组织轮廓增加为成功阈值,对照组89.7%患者与试验组10%患者治疗成功(比值比=77.90;95%CI 13.52-448.80;p<.001)。
  • 胶原基质组术后至1年收缩较结缔组织移植组多0.89 mm(98.3%CI 0.49-1.30)。
  • 胶原基质组边缘骨吸收较结缔组织移植组显著更多(0.39 mm;95%CI 0.05-0.74;p=.026)。

关键数值与推荐

  • 患者美学满意度组间无显著差异(p=.938)。
  • 探诊深度组间无显著差异(p=.917)。
  • 菌斑组间无显著差异(p=.354)。
  • 探诊出血组间无显著差异(p=.783)。
  • 颊侧中部退缩组间无显著差异(p=.915)。

临床怎么用

  • 作者结论认为结缔组织移植仍是增加种植位点软组织厚度的金标准。
  • 作者指出临床医生需权衡胶原基质的获益与其相当程度的移植物吸收。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare connective tissue graft (CTG) with collagen matrix (CMX) in terms of increase in buccal soft tissue profile (BSP) at 1 year when applied at single implant sites. MATERIALS AND METHODS: Patients with a single tooth gap in the anterior maxilla and horizontal mucosa defect were enrolled in a multi-centre randomized controlled trial. All sites had a bucco-palatal bone dimension of at least 6 mm, received a single implant and an immediate implant restoration using a full digital workflow. Sites were randomly allocated to the control (CTG) or test group (CMX) to increase buccal soft tissue thickness. The primary outcome was the increase in BSP at 1 year when compared with the pre-operative situation based on superimposed digital surface models. The changes in BSP over time were registered at a buccal area of interest reaching from 0.5 mm below the soft tissue margin to 4 mm more apical. Secondary outcomes included patient-reported, clinical and aesthetic outcomes. RESULTS: Thirty patients were included per group (control: 50% females, mean age 50.1; test: 53% females, mean age 48.2). The increase in BSP at 1 year was 0.98 mm (98.3% confidence interval [CI]: 0.75-1.20) for CTG and 0.57 mm (98.3% CI: 0.34 to 0.79) for CMX. The mean difference of 0.41 mm (98.3% CI: 0.12 to 0.69) in favour of CTG was significant (p < .001). Based on an arbitrarily chosen threshold for success of 0.75 mm increase in BSP, 89.7% of the patients in the control group and 10% of the patients in the test group were successfully treated (odds ratio = 77.90; 95% CI: 13.52 to 448.80; p < .001). Sites treated with CMX demonstrated 0.89 mm (98.3% CI: 0.49 to 1.30) more shrinkage between postop and 1 year than sites treated with CTG. In addition, CMX resulted in significantly more marginal bone loss (0.39 mm; 95% CI: 0.05 to 0.74; p = .026) than CTG. There were no significant differences between the groups in terms of patients' aesthetic satisfaction (p = .938), probing depth (p = .917), plaque (p = .354), bleeding on probing (p = .783), midfacial recession (p = .915), Pink Esthetic Score (p = .121) and Mucosal Scarring Index (p = .965). CONCLUSIONS: CTG remains the gold standard to increase soft tissue thickness at implant sites. Clinicians need to outweigh the benefits of CMX against considerable resorption of the graft. This study was registered in ClinicalTrials.gov (NCT04210596).

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Cosyn J, Eeckhout C, De Bruyckere T, et al. A multi-centre randomized controlled trial comparing connective tissue graft with collagen matrix to increase soft tissue thickness at the buccal aspect of single implants: 1-year results. J Clin Periodontol. 2022. PMID: 35781692. doi:10.1111/jcpe.13691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。